Media

Here in the media center you will find a range of resources including our latest and archived press releases, speeches and presentations and our photo library.

Press releases

NUCALA (mepolizumab) approved in Canada as the first and only biologic treatment for adults with hypereosinophilic syndrome

15 September 2021

GSK receives authorization under Health Canada’s Interim Order for Sotrovimab for Injection to treat COVID-19 in high-risk adults and adolescents

30 July 2021

BENLYSTA now approved in Canada in addition to standard therapy for treatment of active lupus nephritis in adult patients

30 July 2021

_____